KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Invested Capital (2023 - 2025)

Historic Return on Invested Capital for Aquestive Therapeutics (AQST) over the last 3 years, with Q1 2025 value amounting to 1.08%.

  • Aquestive Therapeutics' Return on Invested Capital rose 3400.0% to 1.08% in Q1 2025 from the same period last year, while for Mar 2025 it was 1.08%, marking a year-over-year increase of 3400.0%. This contributed to the annual value of 0.8% for FY2024, which is 5600.0% up from last year.
  • As of Q1 2025, Aquestive Therapeutics' Return on Invested Capital stood at 1.08%, which was up 3400.0% from 3.95% recorded in Q4 2024.
  • Over the past 5 years, Aquestive Therapeutics' Return on Invested Capital peaked at 3.95% during Q4 2024, and registered a low of 4.65% during Q3 2024.
  • Its 3-year average for Return on Invested Capital is 0.03%, with a median of 0.28% in 2023.
  • Examining YoY changes over the last 5 years, Aquestive Therapeutics' Return on Invested Capital showed a top increase of 37500bps in 2024 and a maximum decrease of -48900bps in 2024.
  • Quarter analysis of 3 years shows Aquestive Therapeutics' Return on Invested Capital stood at 0.2% in 2023, then surged by 1925bps to 3.95% in 2024, then tumbled by -73bps to 1.08% in 2025.
  • Its Return on Invested Capital was 1.08% in Q1 2025, compared to 3.95% in Q4 2024 and 4.65% in Q3 2024.